Common Sense Oncology shared on LinkedIn:
“Clinical trials have identified many important cancer treatments, yet concern exists that some trials prioritize regulatory approval over outcomes that matter most to patients, including meaningful improvement in survival and quality of life.
The Values-toAction Framework, developed by Common Sense Oncology in consultation with people from around the world with lived cancer experience, offers a practical tool to develop more ethical, inclusive, and relevant clinical trials.
Read more about the tool on our website.”
Other articles about Common Sense Oncology on OncoDaily.